HOPE in Action Prospective Multicenter Clinical Trial of HIV+ Deceased Donor Kidney Transplants for HIV+ Recipients

Brief description of study

Use of an HIV+ deceased donor could increase the risk of death, transplant-related or HIV-related complications; alternatively with effective antiretroviral treatment and careful HIV+ donor selection, these risks may be comparable to kidney transplant using an HIV-negative donor. We hypothesize that receiving a kidney transplant from an HIV+ donor will be non-inferior to receiving a kidney transplant from an HIV-negative deceased donor.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    HIV, AIDS
  • Age: - 99 Years
  • Gender: All
Updated on 07 May 2021. Study ID: 830023

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center